Teva Pharmaceutical (TEVA) is trading at new 5-year highs. Shares are up more than 40% over the past year. The stock has strong technical momentum, maintaining a 100% “Buy” opinion from Barchart. TEVA offers international diversification and is favored by both Wall Street and individual investors. Today’s Featured Stock Valued at $36.40 billion, Teva Pharmaceutical (TEVA)  is a global pharmaceutical company that develops, manufactures, and markets both branded and generic drugs, as well as activ ...